Derleme
BibTex RIS Kaynak Göster

Yıl 2019, Cilt: 1 Sayı: 2, 100 - 103, 30.08.2019

Berna Akova Sertaç Argun Kıvanç

Öz

Kaynakça

  • 1. Pineda R. Corneal Transplantation in the Developing World: Lessons Learned and Meeting the Challenge. Cornea. 2015 ;34 Suppl 10:S35-40.
  • 2. WHO. Priority eye diseases.vailable at: http://www.who.int/blindness/causes/priority/en/index8.html.
  • 3. Oliva MS, Schottman T, Gulati M. Turning the tide of corneal blindness. Indian J Ophthalmol. 2012 ;60(5):423-7.
  • 4. Gupta N, Vashist P, Tandon R, Gupta SK, Dwivedi S, Mani K. Prevalence of corneal diseases in the rural Indian population: the Corneal Opacity Rural Epidemiological (CORE) study. Br J Ophthalmol. 2015;99(2):147-52.
  • 5. Wang H, Zhang Y, Li Z, Wang T, Liu P. Prevalence and causes of corneal blindness. Clin Exp Ophthalmol. 2014;42(3):249-53.
  • 6. Tang Y, Wang X, Wang J, Huang W, Gao Y, Luo Y, Lu Y. Prevalence and Causes of Visual Impairment in a Chinese Adult Population: The Taizhou Eye Study. Ophthalmology. 2015 ;122(7):1480-8
  • 7. Farmer LD, Ng SK, Rudkin A, Craig J, Wangmo D, Tsang H, Southisombath K, Griffiths A, Muecke J. Causes of Severe Visual Impairment and Blindness: Comparative Data From Bhutanese and Laotian Schools for the Blind. Asia Pac J Ophthalmol (Phila). 2015;4(6):350-6.
  • 8. Shrestha JB, Gnyawali S, Upadhyay MP. Causes of blindness and visual impairment among students in integrated schools for the blind in Nepal. Ophthalmic Epidemiol. 2012 ;19(6):401-6.
  • 9. Vashist P, Gupta N, Tandon R, Gupta SK, Dwivedi S, Mani K. Population-based assessment of vision-related quality of life in corneal disease: results from the CORE study. Br J Ophthalmol. 2016 ;100(5):588-93.
  • 10. Heegard S, Grossniklaus H. Eye pathology (1st ed.) Heidelberg, Berlin;Springer;2015.
  • 11. Edelhauser HF. The balance between corneal transparency and edema: the Proctor Lecture. Invest Ophthalmol Vis Sci. 2006;47(5):1754-67.
  • 12. Li Q, Fukuda K, Lu Y, Nakamura Y, Chikama T, Kumagai N, Nishida T. Enhancement by neutrophils of collagen degradation by corneal fibroblasts. J Leukoc Biol. 2003 ;74(3):412-9.
  • 13. Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015 ;49:17-45. doi: 10.1016/j.preteyeres.2015.07.002.
  • 14. Huxlin KR, Hindman HB, Jeon KI, Bühren J, MacRae S, DeMagistris M, Ciufo D, Sime PJ, Phipps RP. Topical rosiglitazone is an effective anti-scarring agent in the cornea. PLoS One. 2013 5;8(8):e70785.
  • 15. Trattler W. et al.Cornea handbook ( 1st ed.) Thorofare;Slack incorporated;2010.
  • 16. Kalkanci A, Ozdek S. Ocular fungal infections. Curr Eye Res. 2011;36(3):179-89.
  • 17.Mannis M, Holland E. Cornea Volume 1.Elsevier;2017.
  • 18. Gain P, Jullienne R, He Z, Aldossary M, Acquart S, Cognasse F, Thuret G. Global Survey of Corneal Transplantation and Eye Banking. JAMA Ophthalmol. 2016 ;134(2):167-73.
  • 19. Gomaa A, Comyn O, Liu C. Keratoprostheses in clinical practice - a review. Clin Exp Ophthalmol. 2010 ;38(2):211-24.
  • 20. Alio JL, Abbouda A, Vega-Estrada A. An innovative intrastromal keratoprosthesis surgery assisted by femtosecond laser. Eur J Ophthalmol. 2014 ;24(4):490-3.
  • 21. Alio JL, Abdelghany AA, Abu-Mustafa SK, Zein G. A new epidescemetic keratoprosthesis: pilot investigation and proof of concept of a new alternative solution for corneal blindness. Br J Ophthalmol. 2015;99(11):1483-7.
  • 22. Banitt M. Evaluation and management of glaucoma after keratoprosthesis. Curr Opin Ophthalmol. 2011 ;22(2):133-6.
  • 23. Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012 ;96(6):776-80.
  • 24. Griffith M, Alarcon EI, Brunette I. Regenerative approaches for the cornea. J Intern Med. 2016;280(3):276-86. doi: 10.1111/joim.12502.
  • 25. Bobba S, Di Girolamo N. Contact Lenses: A Delivery Device for Stem Cells to Treat Corneal Blindness. Optom Vis Sci. 2016 ;93(4):412-8.
  • 26. Parekh M, Ferrari S, Sheridan C, Kaye S, Ahmad S. Concise Review: An Update on the Culture of Human Corneal Endothelial Cells for Transplantation. Stem Cells Transl Med. 2016 Feb;5(2):258-64.
  • 27. Geneva: WHO Press;2009: World Health Assembly Document A62/7: Action plan for the prevention of avoidable blindness and visual impairment. 2009-2013;pp.7-17.

Visual Impairmient and blindness among patients with corneal pathologies

Yıl 2019, Cilt: 1 Sayı: 2, 100 - 103, 30.08.2019

Berna Akova Sertaç Argun Kıvanç

Öz

This mini review discusses the corneal blindness worldwide, its epidemiology, treatment and prevention modalities. It gives brief informayion about blinding corneal pathologies

Anahtar Kelimeler

blindness cornea

Kaynakça

  • 1. Pineda R. Corneal Transplantation in the Developing World: Lessons Learned and Meeting the Challenge. Cornea. 2015 ;34 Suppl 10:S35-40.
  • 2. WHO. Priority eye diseases.vailable at: http://www.who.int/blindness/causes/priority/en/index8.html.
  • 3. Oliva MS, Schottman T, Gulati M. Turning the tide of corneal blindness. Indian J Ophthalmol. 2012 ;60(5):423-7.
  • 4. Gupta N, Vashist P, Tandon R, Gupta SK, Dwivedi S, Mani K. Prevalence of corneal diseases in the rural Indian population: the Corneal Opacity Rural Epidemiological (CORE) study. Br J Ophthalmol. 2015;99(2):147-52.
  • 5. Wang H, Zhang Y, Li Z, Wang T, Liu P. Prevalence and causes of corneal blindness. Clin Exp Ophthalmol. 2014;42(3):249-53.
  • 6. Tang Y, Wang X, Wang J, Huang W, Gao Y, Luo Y, Lu Y. Prevalence and Causes of Visual Impairment in a Chinese Adult Population: The Taizhou Eye Study. Ophthalmology. 2015 ;122(7):1480-8
  • 7. Farmer LD, Ng SK, Rudkin A, Craig J, Wangmo D, Tsang H, Southisombath K, Griffiths A, Muecke J. Causes of Severe Visual Impairment and Blindness: Comparative Data From Bhutanese and Laotian Schools for the Blind. Asia Pac J Ophthalmol (Phila). 2015;4(6):350-6.
  • 8. Shrestha JB, Gnyawali S, Upadhyay MP. Causes of blindness and visual impairment among students in integrated schools for the blind in Nepal. Ophthalmic Epidemiol. 2012 ;19(6):401-6.
  • 9. Vashist P, Gupta N, Tandon R, Gupta SK, Dwivedi S, Mani K. Population-based assessment of vision-related quality of life in corneal disease: results from the CORE study. Br J Ophthalmol. 2016 ;100(5):588-93.
  • 10. Heegard S, Grossniklaus H. Eye pathology (1st ed.) Heidelberg, Berlin;Springer;2015.
  • 11. Edelhauser HF. The balance between corneal transparency and edema: the Proctor Lecture. Invest Ophthalmol Vis Sci. 2006;47(5):1754-67.
  • 12. Li Q, Fukuda K, Lu Y, Nakamura Y, Chikama T, Kumagai N, Nishida T. Enhancement by neutrophils of collagen degradation by corneal fibroblasts. J Leukoc Biol. 2003 ;74(3):412-9.
  • 13. Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015 ;49:17-45. doi: 10.1016/j.preteyeres.2015.07.002.
  • 14. Huxlin KR, Hindman HB, Jeon KI, Bühren J, MacRae S, DeMagistris M, Ciufo D, Sime PJ, Phipps RP. Topical rosiglitazone is an effective anti-scarring agent in the cornea. PLoS One. 2013 5;8(8):e70785.
  • 15. Trattler W. et al.Cornea handbook ( 1st ed.) Thorofare;Slack incorporated;2010.
  • 16. Kalkanci A, Ozdek S. Ocular fungal infections. Curr Eye Res. 2011;36(3):179-89.
  • 17.Mannis M, Holland E. Cornea Volume 1.Elsevier;2017.
  • 18. Gain P, Jullienne R, He Z, Aldossary M, Acquart S, Cognasse F, Thuret G. Global Survey of Corneal Transplantation and Eye Banking. JAMA Ophthalmol. 2016 ;134(2):167-73.
  • 19. Gomaa A, Comyn O, Liu C. Keratoprostheses in clinical practice - a review. Clin Exp Ophthalmol. 2010 ;38(2):211-24.
  • 20. Alio JL, Abbouda A, Vega-Estrada A. An innovative intrastromal keratoprosthesis surgery assisted by femtosecond laser. Eur J Ophthalmol. 2014 ;24(4):490-3.
  • 21. Alio JL, Abdelghany AA, Abu-Mustafa SK, Zein G. A new epidescemetic keratoprosthesis: pilot investigation and proof of concept of a new alternative solution for corneal blindness. Br J Ophthalmol. 2015;99(11):1483-7.
  • 22. Banitt M. Evaluation and management of glaucoma after keratoprosthesis. Curr Opin Ophthalmol. 2011 ;22(2):133-6.
  • 23. Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012 ;96(6):776-80.
  • 24. Griffith M, Alarcon EI, Brunette I. Regenerative approaches for the cornea. J Intern Med. 2016;280(3):276-86. doi: 10.1111/joim.12502.
  • 25. Bobba S, Di Girolamo N. Contact Lenses: A Delivery Device for Stem Cells to Treat Corneal Blindness. Optom Vis Sci. 2016 ;93(4):412-8.
  • 26. Parekh M, Ferrari S, Sheridan C, Kaye S, Ahmad S. Concise Review: An Update on the Culture of Human Corneal Endothelial Cells for Transplantation. Stem Cells Transl Med. 2016 Feb;5(2):258-64.
  • 27. Geneva: WHO Press;2009: World Health Assembly Document A62/7: Action plan for the prevention of avoidable blindness and visual impairment. 2009-2013;pp.7-17.
Toplam 27 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Göz Hastalıkları
Bölüm Review Article
Yazarlar

Berna Akova

Sertaç Argun Kıvanç

Yayımlanma Tarihi 30 Ağustos 2019
Kabul Tarihi 16 Aralık 2019
Yayımlandığı Sayı Yıl 2019 Cilt: 1 Sayı: 2

Kaynak Göster

APA Akova, B., & Kıvanç, S. A. (2019). Visual Impairmient and blindness among patients with corneal pathologies. Clinical and Experimental Ocular Trauma and Infection, 1(2), 100-103.
AMA Akova B, Kıvanç SA. Visual Impairmient and blindness among patients with corneal pathologies. CEOTI. Ağustos 2019;1(2):100-103.
Chicago Akova, Berna, ve Sertaç Argun Kıvanç. “Visual Impairmient and Blindness Among Patients With Corneal Pathologies”. Clinical and Experimental Ocular Trauma and Infection 1, sy. 2 (Ağustos 2019): 100-103.
EndNote Akova B, Kıvanç SA (01 Ağustos 2019) Visual Impairmient and blindness among patients with corneal pathologies. Clinical and Experimental Ocular Trauma and Infection 1 2 100–103.
IEEE B. Akova ve S. A. Kıvanç, “Visual Impairmient and blindness among patients with corneal pathologies”, CEOTI, c. 1, sy. 2, ss. 100–103, 2019.
ISNAD Akova, Berna - Kıvanç, Sertaç Argun. “Visual Impairmient and Blindness Among Patients With Corneal Pathologies”. Clinical and Experimental Ocular Trauma and Infection 1/2 (Ağustos 2019), 100-103.
JAMA Akova B, Kıvanç SA. Visual Impairmient and blindness among patients with corneal pathologies. CEOTI. 2019;1:100–103.
MLA Akova, Berna ve Sertaç Argun Kıvanç. “Visual Impairmient and Blindness Among Patients With Corneal Pathologies”. Clinical and Experimental Ocular Trauma and Infection, c. 1, sy. 2, 2019, ss. 100-3.
Vancouver Akova B, Kıvanç SA. Visual Impairmient and blindness among patients with corneal pathologies. CEOTI. 2019;1(2):100-3.
 Kapak Resmi İndir

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License(CC BY-NC-SA 4.0)